The Guardian - Pharmaceutical Industry

SEPTEMBER 9, 2023

Thanks to booming demand for its weight loss treatment Wegovy, the Danish business last week became Europe’s biggest company by stock market value, overtaking the previous holder of that title, French luxury group LVMH. The building looks like a sci-fi film set made by Lego, another stalwart of the Danish economy.

52

52

pharmaphorum

JUNE 1, 2022

GlaxoSmithKline is due to complete the split from its consumer health decision – now renamed Haleon – next month, with a listing for the new company on the London Stock Exchange set for 18 July. A listing on the New York Stock Exchange will follow shortly, according to the pharma group.

Vaccines 105

Vaccines 105

STAT

FEBRUARY 1, 2024

Biotech can’t shake the Fed The XBI, a closely watched index of biotech stocks, turned red for the year yesterday, and not because of a clinical disappointment, a drug pricing scandal, or an M&A rumor that came to nothing. Adjusted earnings are forecast to be between $8.44 Can gene therapy be profitable?

Vaccines 106

Vaccines Communication Insurance 106

European Pharmaceutical Review

MAY 11, 2023

Delivering end-to-end expertise and solutions from research discovery to development, and diagnosis to cure, Revvity provides reagents, consumables, assays, instruments and software to customers in markets ranging from pharma and biotech , diagnostic labs, academia and government agencies. A livestream of the ceremony can be viewed here.

70

70

Digital Pharmacist

JANUARY 25, 2024

Now that we understand the importance of a Google Business Profile, let’s walk through the steps to set one up: Now that we understand the importance of a Google Business Profile, let’s walk through the steps to set one up: In the digital age, online visibility is crucial for businesses to thrive.

Customer Service 94

Customer Service Vaccines 94

Fossil Remedies

FEBRUARY 18, 2022

PCD Pharma Franchise Business. It is because the business is not only promising, but it is going to remain profitable for many years. Therefore, it is a good idea to launch a Pharma Franchise Business. If the right business is launched at the right time, then it will be certainly profitable. What is a Franchise business?

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

JULY 18, 2022

GSK’s consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion). billion last year.

Vaccines 124

Vaccines 124

Fossil Remedies

MARCH 29, 2022

It is every entrepreneur’s dream to launch a business that earns a great profit. The pharma business has become one of the most popular businesses in the last 20 years. It is not an unusual thing that hundreds of new entrepreneurs are entering the market every year with the business model of PCD Pharma Franchise.

98

98

PharmaShots

JUNE 29, 2023

A portmanteau of nutrients and pharmaceuticals, nutraceuticals are colloquially known as medical foods With a market size of $413B in 2021, the nutraceutical market value is forecasted to cross the threshold of $650B by 2030 by marking a remarkable CAGR of 3.9 percent from 2021 to 2030. Revenue: $277.2M

Immunization 40

Immunization 40

PharmaShots

MAY 10, 2023

Bolstered by the inch-perfect result and cutting-edge technology, gradually medical devices have got profoundly embedded in our lives With a global market value of $562.6B The company has divided its business into four segments i.e., Imaging, Diagnostics, Varian, and Advanced Therapies.

Nursing Homes 40

Nursing Homes Hospitals FDA Communication 40

STAT

AUGUST 17, 2023

The health care industry didn’t just provide a safe haven for jittery stock investors in 2022, a year defined by inflation and higher interest rates. By almost every measure, 2022 was a bad year for the stock market.

Nursing Homes 98

Nursing Homes Prescription Filling Insurance Hospitals 98

The Guardian - Pharmaceutical Industry

DECEMBER 7, 2022

You’d think fund mangers would have deployed degree of scepticism after years of overvalued businesses Flotation fever is a dangerous condition, and the bout experienced in early 2021, we can now say, was severe. One could even call the business model clever. Now comes Moonpig.

41

41

pharmaphorum

JANUARY 17, 2022

The Consumer Healthcare business is a Joint Venture between GSK and Pfizer, with GSK holding a majority controlling interest of 68% and Pfizer 32%. GSK explained its decision to reject the proposals, “on the basis that they fundamentally undervalued the Consumer Healthcare business and its future prospects”. billion (£50 billion).

119

119

pharmaphorum

JULY 23, 2021

GlaxoSmithKline has said that Brian McNamara – currently head of its three-year-old consumer health joint venture with Pfizer – will retain the top job at the business after it is hived off into a separate company next year. billion) and leading positions in the US and Chinese markets.

Vaccines 111

Vaccines 111

STAT

SEPTEMBER 15, 2022

Rise and shine, everyone, another busy day is on the way. We always enjoy your tips and insights… Johnson & Johnson announced a stock buyback of up to $5 billion, joining a rush of U.S. So, time to get cracking. Hope you have a smashing day, and do stay in touch.

68

68

PharmaShots

FEBRUARY 21, 2023

With the growing influence of radiopharmaceutical companies in oncology, the companies hold a firm grasp on the market. With the expanding acceptance among HCPs, patients, and researchers, radiopharmaceutical companies are estimated to touch the $7.5B threshold by 2026.

FDA 56

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 56

Pharmaceutical Technology

APRIL 17, 2023

NKGen Biotech, a clinical-stage natural killer (NK) cell therapy firm, has signed a definitive agreement to combine its business operations with Graf Acquisition. Graf is also anticipated to be listed on the New York Stock Exchange, NYSE American and Nasdaq under the ticker symbol ‘NKGN’.

98

98

PharmaShots

MAY 23, 2023

Propelled by constant innovatory winds, the Cell and Gene therapy market is anticipated to grow by 20 percent year-over-year through 2025. Approved Cell and Gene Therapy: Collategene Founded Year: 1999 Total Employees: ~140 Headquarters: Osaka, Japan Market Cap: $162.8M With a total revenue of $52B, Merck & Co. Total Revenue: $3.6M

FDA 58

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 58

Pharmaceutical Technology

JULY 6, 2022

Talks of a bear market in the biotech sector do not seem to pass, with news of companies falling into administration and layoffs becoming a recurrence. Just last week, trading for 4D Pharma , a British biotech, was suspended on the London Stock Exchange’s Alternative Investment Market , and the company will be delisted from NASDAQ on July 7.

129

129

European Pharmaceutical Review

JULY 11, 2023

WuXi XDC) on the Main Board of the Hong Kong Stock Exchange (HKEX). As some of the opportunities in the fast-growing global bioconjugate market are currently beyond the business scope of WuXi Bio, the proposed spin-off will facilitate the company to capture the market.

59

59

Pharmaceutical Technology

NOVEMBER 8, 2022

According to the deal, the purchase price, contingent on adjustments, has to be paid by Fulgent Genetics as a combination of cash on hand and its shares of common stock. With the takeover, Fulgent Genetics intends to transform into a completely integrated precision medicine firm focusing on oncology from a genomic diagnostic business.

52

52

Pharmaceutical Technology

OCTOBER 20, 2022

Ayala Pharmaceuticals has signed a definitive merger agreement with biotechnology company Advaxis, which discovers, develops and markets immunotherapies. The business combination would result in a merged company that will mainly focus on developing and marketing Ayala’s AL102 and Advaxis’ ADXS-504.

52

52

pharmaphorum

JANUARY 11, 2021

US wholesale giant AmerisourceBergen is to buy the majority of Walgreens Boots Alliance’s wholesaling business for around $6.5 AmerisourceBergen will pay $6.275 billion in cash and around 2 million shares of its common stock for Alliance Healthcare in a deal to support its global distribution business.

84

84

pharmaphorum

JULY 25, 2022

The all-stock transaction values Zymergen at an approximately $300 million, a fraction of the $1 billion it raised in venture funding with another $530 million from its initial public offering in April 2021. ” The post Ginkgo buys Zymergen, but may shed drug discovery business appeared first on.

52

52

pharmaphorum

NOVEMBER 27, 2022

Supply chain challenges take many forms in pharma – from capacity issues, to managing excess safety stock, and ensuring accurate supplier communication. Cutting down on safety stock. This means batch sizes can be tailored to daily demands rather than market forecasts. Reducing capacity issues.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

pharmaphorum

NOVEMBER 13, 2020

Since Covid-19 hit, many industries have shifted a heavier weighting of their business into the online world, relying on e-commerce and digital engagement to counterbalance the reduced ability for physical interactions. And for those pharma businesses that can get it right, digital adoption is certainly the way forward.

Pharmaceutical Companies 124

Pharmaceutical Companies Pharmaceutical Companies 124

Fossil Remedies

DECEMBER 29, 2022

There are many types of pharma businesses and one can choose any of them. If you are running a small business in this niche, then it is time for you to invest in any of the good pharma companies. You can earn and develop a profitable business by offering a well-established platform. It is a business with low-risk investment.

52

52

PharmaShots

APRIL 25, 2023

In 2022, the global market size of RNAi drug delivery was valued at $69.2B. Founded Year: 1994 Total Employees: ~120 Headquarters: London, United Kingdom Market Cap: $189.2M Founded Year: 1994 Total Employees: ~120 Headquarters: London, United Kingdom Market Cap: $189.2M R&D Expenditure: $64.2M R&D Expenditure: $84.4M

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Packaging Immunization Vaccines 40

Pharmaceutical Technology

SEPTEMBER 22, 2022

Sesen Bio has signed a definitive merger agreement to combine its business with Carisma Therapeutics and create a clinical-stage biotechnology firm in an all-stock deal. . Carisma president and CEO Steven Kelly will lead the combined business. Topic sponsors are not involved in the creation of editorial content.

Immunization 52

Immunization 52

pharmaphorum

FEBRUARY 28, 2022

billion in cash and providing another $1 billion in stock under the terms of the deal, which has been approved by the boards of both companies and is expected to close in the second half of this year. India’s Biocon has expanded its pipeline of biosimilars with a $3.3 Biocon is paying $2.3 billion.

Customer Service 102

Customer Service 102

Pharmaceutical Technology

SEPTEMBER 6, 2022

Business optimism improved in August 2022 compared to July 2022, according to an ongoing poll by Verdict, despite businesses expressing concern over inflation, particularly in raw materials and energy costs. Business confidence improves in three of the UK’s regions. Indian firms witness stronger growth and softer cost pressures.

52

52

DiversifyRx

MARCH 3, 2023

When you open a pharmacy, you open a business. Create a business plan for your pharmacy. A business plan is the first and most crucial step in the investment process. Read DiversifyRx’s Business Plans For Pharmacies article for more information on how to craft an exceptional business plan.

Independent Pharmacies 98

Independent Pharmacies Customer Service Hospitals Vaccines 98

pharmaphorum

JANUARY 6, 2023

With the US economy teetering on a recession, sales and marketing budgets are expected to take a hit among businesses across sectors. The notion of making fewer mistakes with your existing business practices, rather than expanding your footprint, might seem overly conservative for a robust industry. Ensuring patient access.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Digital Pharmacist

NOVEMBER 23, 2022

Section 179 is a tax deduction for businesses. Section 179 is a tax code created to help businesses. By allowing businesses to deduct the full amount of the purchase price of equipment (up to certain limits). By allowing businesses to deduct the full amount of the purchase price of equipment (up to certain limits).

Communication 52

Communication 52

pharmaphorum

OCTOBER 1, 2021

Shares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Exchange yesterday, rising nearly 50% to propel its valuation up towards the £5 billion ($6.7 The post Oxford Nanopore makes stellar debut on UK stock market appeared first on. billion) mark.

Documentation 52

Documentation Vaccines 52

pharmaphorum

MARCH 1, 2021

billion windfall will be a boost to the UK pharma’s coffers during a busy time. AZ has a rich development pipeline and its busy completing its largest acquisition, the $39 billion purchase of rare diseases specialist Alexion. billion this year, which is significantly higher than market expectations.

Vaccines 64

Vaccines 64

pharmaphorum

OCTOBER 28, 2020

Stocks for Exact Sciences leaped 33% after it announced the acquisition of liquid biopsy rival Thrive and UK start-up Base Genomics. Exact Sciences said it has agreed to buy Thrive for a cash and stock deal worth up to $2.15 billion, positioning it as a leader in the cancer-screening market.

64

64